ClC-7 links PIKfyve inhibition to Rab-dependent LRRK2 activity at lysosomes
Journal of Cell Biology · 02.11.2026 · 225 (11)
DOI: 10.1083/jcb.202511137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, online erschienen am 20.10.2026. Verfasst von Devin Clegg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Cell Biology, Yale University School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Lysosomes, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, rab GTP-Binding Proteins, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aligning Science Across Parkinson's disease, NIGMS NIH HHS, Michael J. Fox Foundation for Parkinson's Research.
Abstract (Originalsprache)
Increased activity of leucine-rich repeat kinase 2 (LRRK2) confers Parkinson’s disease risk. LRRK2 dynamically localizes to lysosomal membranes in response to various stresses, yet the mechanisms by which distinct lysosomal perturbations are communicated to LRRK2 remain unclear. Here, we show that inhibition of the lysosomal lipid kinase PIKfyve promotes LRRK2 recruitment and signaling through a pathway that requires the lysosomal chloride/proton antiporter ClC-7. ClC-7 in turn controls the accumulation of multiple Rab GTPases on lysosomes. LRRK2 signaling under these conditions requires its established Rab-binding surfaces, with Rab12 contributing significantly to this response. This pathway operates independently of CASM. In contrast, lysosomal stresses that induce CASM require both Rab-binding sites on LRRK2 and GABARAP for robust LRRK2 signaling. These findings identify ClC-7–dependent lysosomal remodeling and Rab accumulation as key features linking PIKfyve inhibition to LRRK2 signaling and reveal that distinct lysosomal stresses engage different combinations of Rab and GABARAP inputs to activate LRRK2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.
- Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.
- Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA.
- Wu Tsai Institute, Yale University School of Medicine , New Haven, CT, USA.
- Aligning Science Across Parkinson's (ASAP) Collaborative Research Network , Chevy Chase, MD, USA.
- Kavli Institute for Neuroscience, Yale University School of Medicine , New Haven, CT, USA.
ORCID-Profile: Devin Clegg, Amanda Bentley-DeSousa, Agnes Roczniak-Ferguson, Shawn M Ferguson
Förderung
- Aligning Science Across Parkinson's disease
- NIGMS NIH HHS
- Michael J. Fox Foundation for Parkinson's Research
- NIH HHS
- National Institutes of Health
- Aligning Science Across Parkinson’s disease
- Michael J. Fox Foundation for Parkinson’s Research
Zitieren
APA
Clegg, D., Bentley-DeSousa, A., Roczniak-Ferguson, A., & Ferguson, S. M. (2026). ClC-7 links PIKfyve inhibition to Rab-dependent LRRK2 activity at lysosomes. Journal of Cell Biology, 225(11). https://doi.org/10.1083/jcb.202511137
Vancouver
Clegg D, Bentley-DeSousa A, Roczniak-Ferguson A, Ferguson SM. ClC-7 links PIKfyve inhibition to Rab-dependent LRRK2 activity at lysosomes. Journal of Cell Biology. 2026;225(11). doi:10.1083/jcb.202511137
BibTeX
@article{Clegg2026,
author = {Clegg, Devin and Bentley-DeSousa, Amanda and Roczniak-Ferguson, Agnes and Ferguson, Shawn M},
title = {ClC-7 links PIKfyve inhibition to Rab-dependent LRRK2 activity at lysosomes},
journal = {Journal of Cell Biology},
year = {2026},
volume = {225},
number = {11},
doi = {10.1083/jcb.202511137}
}
EUVIMED